Back to Search
Start Over
iTeos Therapeutics announces first patient dosed in GALAXIES Lung-301 study
- Source :
- The Fly. July 8, 2024
- Publication Year :
- 2024
-
Abstract
- iTeos Therapeutics (ITO)S announced the dosing of the first patient in GALAXIES Lung-301, a global, randomized, double-blind Phase 3 registrational clinical trial of belrestotug + dostarlimab versus placebo + pembrolizumab [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.800465620